Skip to main content
https://pbs.twimg.com/media/Fg9mULpWQAAwI77.png
Song et al. Korean study shows better persistence of tocilizumab than TNFi as first-line biologic in RA. No difference in incidence of TB. @RheumNow #ACR22 Abstr#0887 https://t.co/EuQkfDZd77 https://t.co/VxJmKEzAVY
Richard Conway
13-11-2022
×